{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:48:55Z","timestamp":1793674135254,"version":"4.5.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.biopha.2023.114494","type":"journal-article","created":{"date-parts":[[2023,3,12]],"date-time":"2023-03-12T11:51:22Z","timestamp":1678621882000},"page":"114494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells"],"prefix":"10.1016","volume":"161","author":[{"given":"Nayanendu","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du-San","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle P.","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Robev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Goldgur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jason","family":"De La Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"de Stanchina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Janes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimiter S.","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitar B.","family":"Nikolov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2023.114494_bib1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/jclinpath-2017-204739","article-title":"Cancer stem cells in colorectal cancer: a review","volume":"71","author":"Munro","year":"2018","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.biopha.2023.114494_bib2","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1093\/hmg\/11.21.2615","article-title":"The disintegrin\/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts","volume":"11","author":"Hartmann","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biopha.2023.114494_bib3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nrc2459","article-title":"The ADAMs: signalling scissors in the tumour microenvironment","volume":"8","author":"Murphy","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2023.114494_bib4","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/0008-5472.CAN-10-2817","article-title":"Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations","volume":"71","author":"Fischer","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.114494_bib5","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1158\/0008-5472.CAN-11-1704","article-title":"DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo","volume":"71","author":"Li","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.114494_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ccr.2012.07.016","article-title":"Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells","volume":"22","author":"Domingo-Domenech","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2023.114494_bib7","doi-asserted-by":"crossref","first-page":"E2939","DOI":"10.1073\/pnas.1206400109","article-title":"Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy","volume":"109","author":"McAuliffe","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2023.114494_bib8","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10495-013-0883-x","article-title":"Gamma-secretase inhibition attenuates oxaliplatin-induced apoptosis through increased Mcl-1 and\/or Bcl-xL in human colon cancer cells","volume":"18","author":"Timme","year":"2013","journal-title":"Apoptosis: Int. J. Program. Cell Death"},{"key":"10.1016\/j.biopha.2023.114494_bib9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1158\/0008-5472.CAN-08-2088","article-title":"Gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity","volume":"69","author":"Meng","year":"2009","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.114494_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.semcdb.2012.01.016","article-title":"Therapeutic approaches to modulating Notch signaling: current challenges and future prospects","volume":"23","author":"Groth","year":"2012","journal-title":"Semin Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2023.114494_bib11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/bies.200900140","article-title":"Notch: Implications of endogenous inhibitors for therapy","volume":"32","author":"Dikic","year":"2010","journal-title":"Bioessays"},{"key":"10.1016\/j.biopha.2023.114494_bib12","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/nature08878","article-title":"Therapeutic antibody targeting of individual Notch receptors","volume":"464","author":"Wu","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2023.114494_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1101\/gad.1039703","article-title":"The ADAMs family of metalloproteases: multidomain proteins with multiple functions","volume":"17","author":"Seals","year":"2003","journal-title":"Genes Dev."},{"issue":"2005","key":"10.1016\/j.biopha.2023.114494_bib14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2005.08.014","article-title":"Adam Meets Eph: An ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans","volume":"123","author":"Janes","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2023.114494_bib15","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1083\/jcb.200206023","article-title":"The cysteine-rich domain regulates ADAM protease function in vivo","volume":"159","author":"Smith","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2023.114494_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000215","article-title":"Cytoplasmic relaxation of active Eph controls ephrin shedding by ADAM10","volume":"7","author":"Janes","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.biopha.2023.114494_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrd4252","article-title":"Therapeutic modulation of Notch signalling--are we there yet?","volume":"13","author":"Andersson","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2009","key":"10.1016\/j.biopha.2023.114494_bib18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bmc.2008.11.067","article-title":"Current perspective of TACE inhibitors: a review","volume":"17","author":"DasGupta","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2023.114494_bib19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejcb.2010.11.005","article-title":"The \"A Disintegrin And Metalloproteases\" ADAM10 and ADAM17: novel drug targets with therapeutic potential?","volume":"90","author":"Saftig","year":"2011","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.biopha.2023.114494_bib20","doi-asserted-by":"crossref","first-page":"702","DOI":"10.7150\/ijbs.9326","article-title":"Targeting the sheddase activity of ADAM17 by an anti-ADAM17 antibody D1 (A12) inhibits head and neck squamous cell carcinoma cell proliferation and motility via blockage of bradykinin induced HERs transactivation","volume":"10","author":"Huang","year":"2014","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2023.114494_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/BJ20120433","article-title":"A novel bispecific single-chain antibody for ADAM17 and CD3 induces T-cell-mediated lysis of prostate cancer cells","volume":"445","author":"Yamamoto","year":"2012","journal-title":"Biochem J."},{"key":"10.1016\/j.biopha.2023.114494_bib22","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1158\/1535-7163.MCT-14-1040","article-title":"A monoclonal antibody to ADAM17 inhibits tumor growth by inhibiting EGFR and Non-EGFR-mediated pathways","volume":"14","author":"Rios-Doria","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2023.114494_bib23","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1242\/jcs.112631","article-title":"Antibodies binding the ADAM10 substrate recognition pocket inhibit Eph function","volume":"125","author":"Atapattu","year":"2012","journal-title":"J. Cell Sci."},{"issue":"9","key":"10.1016\/j.biopha.2023.114494_bib24","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.20151095","article-title":"An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth","volume":"213","author":"Atapattu","year":"2016","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.biopha.2023.114494_bib25","first-page":"759","article-title":"A colon cancer cell line (LIM1215) derived from a patient with inherited nonpolyposis colorectal cancer","volume":"74","author":"Whitehead","year":"1985","journal-title":"J. Natl. Cancer Inst."},{"issue":"29","key":"10.1016\/j.biopha.2023.114494_bib26","doi-asserted-by":"crossref","first-page":"9953","DOI":"10.1073\/pnas.0804797105","article-title":"Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3","volume":"105","author":"Xu","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2023.114494_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.canlet.2021.10.041","volume":"525","author":"Baek","year":"2022","journal-title":"Cancer Lett."},{"issue":"17","key":"10.1016\/j.biopha.2023.114494_bib28","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","article-title":"Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cytotoxicity","volume":"267","author":"O\u2019Brien","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.biopha.2023.114494_bib29","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1158\/1535-7163.MCT-14-1040","article-title":"A monoclonal antibody to ADAM17 inhibits tumor growth by inhibiting EGFR and non-EGFR-mediated pathways","volume":"14","author":"Rios-Doria","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2023.114494_bib30","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2144\/97225rr03","article-title":"Optimization of cellular ELISA for assay of surface antigens on human synoviocytes","volume":"22","author":"Smith D","year":"1997","journal-title":"BioTechniques"},{"issue":"7","key":"10.1016\/j.biopha.2023.114494_bib31","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.cell.2017.11.014","article-title":"Structural basis for regulated proteolysis by the \u03b1-Secretase ADAM10","volume":"171","author":"Seegar","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2023.114494_bib32","series-title":"Handbook of Proteolytic Enzymes","first-page":"1315","article-title":"Tumor Necrosis Factor alpha -Converting Enzyme","author":"Black","year":"1998"},{"key":"10.1016\/j.biopha.2023.114494_bib33","first-page":"82549","article-title":"Targeting a chemorefractory COLO205 (BRAF V600E) cell line using substituted benzo[\u03b1]phenoxazines","volume":"5","author":"Pal","year":"2015","journal-title":"RCS Adv."},{"key":"10.1016\/j.biopha.2023.114494_bib34","first-page":"35","article-title":"The expression patterns of ER, PR, HER2, CK5\/6, EGFR, Ki-67 and AR by immunohistochemical analysis in breast cancer cell lines","volume":"4","author":"Subik","year":"2010","journal-title":"Breast Cancer (Auckl.)"},{"key":"10.1016\/j.biopha.2023.114494_bib35","article-title":"Ovarian cancer cell lines derived from non-serous carcinomas migrate and invade more aggressively than those derived from high-grade serous carcinomas","volume":"9","author":"Potts","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.114494_bib36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41419-017-0119-z","article-title":"Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-\u03baB(p65) pathway","volume":"9","author":"Long","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2023.114494_bib37","first-page":"2379","article-title":"Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung","volume":"53","author":"Rusch","year":"1993","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.114494_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101265","article-title":"Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells","volume":"15","author":"Saha","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.biopha.2023.114494_bib39","doi-asserted-by":"crossref","unstructured":"C.H. Lipper, E.D. Egan, K.K. Gabriel, S.C. Blacklow. Structural Basis for Selective Proteolysis of ADAM10 Substrates at Membrane-Proximal Sites. BioRxiv. (2022).","DOI":"10.1101\/2022.10.22.513345"},{"key":"10.1016\/j.biopha.2023.114494_bib40","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1158\/0008-5472.CAN-07-0991","article-title":"Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis","volume":"67","author":"Gavert","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.114494_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/jso.21781","article-title":"ADAM 10 is associated with gastric cancer progression and prognosis of patients","volume":"103","author":"Wang","year":"2011","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.biopha.2023.114494_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00499","article-title":"Targeting ADAM10 in cancer and autoimmunity","volume":"11","author":"Smith","year":"2020","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2023.114494_bib43","doi-asserted-by":"crossref","first-page":"262","DOI":"10.7150\/jca.7988","article-title":"Early detection of colorectal cancer recurrence in patients undergoing surgery with curative intent: current status and challenges","volume":"5","author":"Young","year":"2014","journal-title":"J. Cancer"},{"key":"10.1016\/j.biopha.2023.114494_bib44","doi-asserted-by":"crossref","unstructured":"K. Salaita, P.M. Nair, R.S. Petit, R.M. Neve, D. Das, J.W. Gray, J.T. Groves. Restriction of receptor movement alters cellular response: physical force sensing by EphA2. Science., 327(5971): 1380\u20131385.","DOI":"10.1126\/science.1181729"},{"issue":"31","key":"10.1016\/j.biopha.2023.114494_bib45","doi-asserted-by":"crossref","first-page":"22871","DOI":"10.1074\/jbc.M113.462267","article-title":"Activity of ADAM17 (a disintegrin and metalloprotease 17) is regulated by its noncatalytic domains and secondary structure of its substrates","volume":"288","author":"Stawikowska","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114494_bib46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.canlet.2019.10.003","article-title":"ADAM proteases: emerging role and targeting of the non-catalytic domains","volume":"467","author":"Saha","year":"2019","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2023.114494_bib47","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1744980","article-title":"ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance","volume":"9","author":"Orme","year":"2020","journal-title":"Oncoimmunology"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223002822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223002822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:16:28Z","timestamp":1781280988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223002822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":47,"alternative-id":["S0753332223002822"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114494","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114494","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114494"}}